The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis

Maloney, J., Bernstein, D. I., Hébert, J., White, M., Fisher, R., Casale, T. B., … Nolte, H. (2014). The efficacy and safety of the short ragweed sublingual immunotherapy tablet MK-3641 is similar in asthmatic and nonasthmatic subjects treated for allergic rhinitis with/without conjunctivitis. Allergy, Asthma and Clinical Immunology, 10(2). https://doi.org/10.1186/1710-1492-10-S2-A17